APA (7th ed.) Citation

A, F., J, W., T, C., X, W., T, B., K, B., . . . Y, K. (2026). Musculoskeletal Adverse Events Following BCMA CAR T-Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune Correlates. Transplantation and cellular therapy, 32(5), 559.e1-559.e11. https://doi.org/10.1016/j.jtct.2026.02.009

Chicago Style (17th ed.) Citation

A, Feng, et al. "Musculoskeletal Adverse Events Following BCMA CAR T-Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune Correlates." Transplantation and Cellular Therapy 32, no. 5 (2026): 559.e1-559.e11. https://doi.org/10.1016/j.jtct.2026.02.009.

MLA (9th ed.) Citation

A, Feng, et al. "Musculoskeletal Adverse Events Following BCMA CAR T-Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune Correlates." Transplantation and Cellular Therapy, vol. 32, no. 5, 2026, pp. 559.e1-559.e11, https://doi.org/10.1016/j.jtct.2026.02.009.